Table 2.

The comparisons of NMOSD and MS patients at acute and stable phases

Variable		NMOSD		MS		P1	P2	P3	P4
		Acute phase (n = 47)	Stable phase (n = 21)	Acute phase (n = 28)	Stable phase (n = 25)
BMI, kg/m2	Adjusteda	21.72 ± 1.08	23.33 ± 1.33	20.36 ± 0.26	20.19 ± 0.46	<0.001	<0.001	<0.001	0.098
Body fat%	Adjusteda	29.63 ± 3.90	32.26 ± 4.31	26.46 ± 2.30	27.23 ± 1.62	<0.001	<0.001	0.016	0.169
Systolic BP (mmHg)	Adjusteda	115.5 ± 1.7	113.6 ± 0.84	111.1 ± 1.5	111.1 ± 6.0	<0.001	0.069	<0.001	0.984
Diastolic BP (mmHg)	Adjusteda	74.1 ± 1.7	72.2 ± 0.3	71.5 ± 1.5	70.7 ± 0.8	<0.001	<0.001	<0.001	0.024
Pulse pressure (mmHg)	Adjusteda	41.4 ± 0.01	41.3 ± 0.5	39.6 ± 0.02	40.4 ± 6.7	<0.001	0.531	0.245	0.554
Mean arterial pressure (mmHg)	Adjusteda	87.9 ± 1.7	86.0 ± 0.5	84.7 ± 1.5	84.2 ± 1.5	<0.001	<0.001	<0.001	0.203

P1= refers to the comparison between acute phase in NMOSD and acute phase in MS. P2= refers to the comparison between stable phase in NMOSD and stable phase in MS. P3= refers to the comparison between acute phase and stable phase in NMOSD. P4= refers to the comparison between acute phase and stable phase in MS.

Abbreviations: BMI, body mass index; BP, blood pressure; IQR, interquartile range; MS, multiple sclerosis; NMOSD, neuromyelitis optica spectrum disorder; Pulse pressure, systolic BP‐diastolic BP.

^aThe adjusted model was calculated using a multivariable linear regression model, adjusted by age.